The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 22, 2023

Filed:

Nov. 13, 2018
Applicants:

The University of Chicago, Chicago, IL (US);

Imperial College Innovations Limited, London, GB;

Inventors:

Jeffrey A. Hubbell, Chicago, IL (US);

Anna M. Randi, London, GB;

Jun Ishihara, Chicago, IL (US);

Ako Ishihara, Chicago, IL (US);

Priscilla Briquez, Chicago, IL (US);

Richard Starke, London, GB;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07K 5/00 (2006.01); C07K 7/00 (2006.01); C07K 16/00 (2006.01); C07K 17/00 (2006.01); C07K 14/00 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); C07K 14/475 (2006.01); A61P 17/02 (2006.01); A61K 38/16 (2006.01); C07K 14/78 (2006.01); A61L 27/22 (2006.01); C07K 16/18 (2006.01); A61K 9/00 (2006.01); A61K 9/70 (2006.01); C07K 14/705 (2006.01); A61K 47/64 (2017.01); C07K 14/81 (2006.01); A61K 47/69 (2017.01); A61K 38/39 (2006.01);
U.S. Cl.
CPC ...
C07K 14/78 (2013.01); A61K 9/0024 (2013.01); A61K 9/7007 (2013.01); A61K 38/00 (2013.01); A61K 38/18 (2013.01); A61K 38/39 (2013.01); A61K 47/6435 (2017.08); A61K 47/6903 (2017.08); A61L 27/22 (2013.01); A61P 17/02 (2018.01); C07K 14/475 (2013.01); C07K 14/70546 (2013.01); C07K 14/8121 (2013.01); C07K 16/18 (2013.01); A61L 2300/412 (2013.01); C07K 2317/55 (2013.01); C07K 2319/70 (2013.01);
Abstract

The methods and compositions described herein address the need in the art by providing peptides and polypeptides comprising a growth factor binding domain. In some embodiments, the peptides have an amino acid sequence that is at least 80% identical to one of SEQ ID NOS:1-7, 13-15, 49-50, or 66-70, or a fragment thereof; wherein the peptide is less than 300 amino acids in length.


Find Patent Forward Citations

Loading…